Literature DB >> 29306435

Fluorescence-Quenched Substrates for Quantitative Live Cell Imaging of Glucocerebrosidase Activity.

Roger A Ashmus1, David L Shen1, David J Vocadlo2.   

Abstract

Glucocerebrosidase (GCase) is a lysosomal glycoside hydrolase that cleaves the glycolipid glucosylceramide (GlcCer). Deficiencies of this enzyme lead to accumulation of GlcCer and the development of the lysosomal storage disease known as Gaucher's disease. Recently, loss-of-function mutations in the GBA1 gene that encodes GCase have been linked to Parkinson's disease. Currently pursued therapeutic strategies to increase GCase involve enzyme replacement therapy, chemical chaperone therapy, and GCase activators. A challenge associated with advancing such strategies is to efficiently monitor GCase activity within the lysosomes of live cells. In this chapter, we review the design and use of the fluorescent-quenched probe GBA1-FQ2 to quantitatively measure GCase activity in lysosomes of live cells.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FRET-based (dark-to-light) substrate; Gaucher's disease; Glucocerebrosidase; Glucosylceramide; Glycolipid; Glycoside hydrolase; Live cell imaging substrate; Lysosomal enzyme; Parkinson's disease

Mesh:

Substances:

Year:  2017        PMID: 29306435     DOI: 10.1016/bs.mie.2017.06.014

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

Review 1.  Lysosomal dysfunction in neurodegeneration: emerging concepts and methods.

Authors:  Vinod Udayar; Yu Chen; Ellen Sidransky; Ravi Jagasia
Journal:  Trends Neurosci       Date:  2022-01-13       Impact factor: 13.837

Review 2.  Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.

Authors:  Loredana Leggio; Greta Paternò; Silvia Vivarelli; Francesca L'Episcopo; Cataldo Tirolo; Gabriele Raciti; Fabrizio Pappalardo; Carmela Giachino; Salvatore Caniglia; Maria Francesca Serapide; Bianca Marchetti; Nunzio Iraci
Journal:  Biomolecules       Date:  2020-09-16

3.  Xylose-Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase.

Authors:  Qin Su; Sybrin P Schröder; Lindsey T Lelieveld; Maria J Ferraz; Marri Verhoek; Rolf G Boot; Herman S Overkleeft; Johannes M F G Aerts; Marta Artola; Chi-Lin Kuo
Journal:  Chembiochem       Date:  2021-09-13       Impact factor: 3.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.